Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

AARTI DRUGS LTD. - 524348 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 This has reference to the 36th Annual General Meeting (AGM) of the Company which was held on Saturday, September 4, 2021 at 11:30 AM and concluded at 12:50 PM through Video Conferencing for the matters as stated in the Notice sent to the Shareholders. We would like to inform you that the resolution set forth in the notice have been passed by members of the Company with requisite majority. We are enclosing herewith the scrutinizer's report and voting results of the AGM
05-09-2021
Bigul

Aarti Drugs Ltd - 524348 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the details of the proceedings of 36th Annual General Meeting (AGM) of the Company held on Saturday, September 4, 2021 at 11:30 AM through Video Conferencing.
05-09-2021
Bigul

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificates
04-09-2021
Bigul

Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Analyst Meet
02-09-2021
Bigul

Aarti Drugs Ltd - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we inform you that the Company has issued Duplicate share certificates in lieu of original share certificates.
01-09-2021
Bigul

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Please find attached herewith transcript of Q1 FY22 Earning Conference Call.
31-08-2021
Bigul

Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per the details below.
30-08-2021
Bigul

Aarti Drugs Ltd - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificates.
27-08-2021
Bigul

Aarti Drugs Ltd - 524348 - Disclosure Regarding Submission Of Application For Re-Classification Of Promoter Group

 As per Regulation 31A(8)(c) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that, Company has submitted the application for Re-classification of Promoter Group as mentioned below with BSE Limited and National Stock Exchange of India Limited.
22-08-2021
Bigul

AARTI DRUGS LTD. - 524348 - Disclosure Regarding Submission Of Application For Re-Classification Of Promoter Group

 As per Regulation 31A(8)(c) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that, Company has submitted the application for Re-classification of Promoter Group as mentioned below with BSE Limited and National Stock Exchange of India Limited.
22-08-2021
Next Page
Close

Let's Open Free Demat Account